Clinical Coagulation, Malmö
351 – 360 of 630
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Risk factors for hemorrhage during local intra-arterial thrombolysis for lower limb ischaemia
(
- Contribution to journal › Article
-
Mark
Inhibitors in haemophilia A - Prevention, current management and personalised therapy perspectives
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Bone Mineral Density in Haemophilila: A Treatment Outcome
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Inhibitors in haemophilia A - Prevention, current management and personalised therapy perspectives
(
- Contribution to journal › Article
-
Mark
The international factor IX treatment network survey
(
- Contribution to journal › Published meeting abstract
-
Mark
Quality of life, physical function and MRI T2*in elderly low-risk MDS patients treated to a haemoglobin level of >= 120 g/L with darbepoetin alfa +/- filgrastim or erythrocyte transfusions
(
- Contribution to journal › Article
-
Mark
The pro-FEIBA study: prophylactic dosing of Factor Eight Inhibitor Bypassing Activity (FEIBA) reduces bleeding frequency in haemophilia a patients with inhibitors
(
- Contribution to journal › Published meeting abstract
-
Mark
Osteoporosis: a real problem in haemophilia?
(
- Contribution to journal › Published meeting abstract
-
Mark
Optimizing patient therapy - optimal dosing: when is enough enough?
(
- Contribution to journal › Article
-
Mark
Haematuria and hypertension in haemophilia - the H3 study
(
- Contribution to journal › Published meeting abstract